drugset / Trial / NCT02651714
Tradipitant in Treatment-resistant Pruritus Associated With Atopic Dermatitis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a multicenter, randomized, double-blind, placebo-controlled study to be conducted in the United States in subjects with treatment-resistant pruritus diagnosed with atopic dermatitis.
Timeline
- Start
- 2016-01-19
- Primary completion
- 2017-08-04
- Completion
- 2017-08-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tradipitant | Small molecule | — | Oral |